Health Catalyst Reports 11% Revenue Decline and $111M Net Loss in Q1 2026

Health Catalyst, Inc. reported a significant decline in financial performance for the first quarter of 2026, with total revenue of $70.8 million, down 11% from $79.4 million in the same period last year. The decrease was primarily attributed to the exit from lower-margin technology-enabled managed services (TEMS) arrangements and a reduction in full-time equivalent (FTE)-based professional services contracts. The company's technology revenue, which accounted for 70% of total revenue, fell to $49.5 million from $51.5 million, while professional services revenue dropped to $21.3 million from $27.9 million.

The company experienced a net loss of $111.0 million for the quarter, a substantial increase from the $23.7 million loss reported in the prior year. This increase was largely driven by a $95.5 million goodwill impairment charge, reflecting declines in stock price and market capitalization. Operating expenses surged to $141.9 million, compared to $56.4 million in the previous year, primarily due to the goodwill impairment and restructuring costs associated with workforce reductions.

Health Catalyst's operational metrics showed a mixed picture. The company reported a total of 73.7 million shares outstanding as of March 31, 2026, an increase from 72.0 million shares at the end of 2025. The company also noted a significant increase in deferred revenue, which rose to $70.0 million from $56.5 million, indicating a growing backlog of client contracts. However, the company faced challenges with client retention during the migration from its legacy DOS platform to the new Ignite platform, with $12.5 million in annual recurring revenue (ARR) identified as at risk.

Strategically, Health Catalyst has been focusing on enhancing its technology offerings and improving client retention. The company is in the process of migrating clients to its Ignite platform, which has faced some challenges, including client churn and down-selling. To address these issues, Health Catalyst has tailored its migration approach to better meet individual client needs. The company is also implementing Project Nexus, a strategic initiative aimed at transforming its operating model and optimizing its cost structure, which is expected to result in a workforce reduction of approximately 9% in the second quarter of 2026.

Looking ahead, Health Catalyst anticipates continued pressure on revenue due to macroeconomic challenges, including high inflation and labor costs, which have affected the healthcare sector. The company remains committed to improving its operational efficiency and leveraging its data and analytics capabilities to drive growth. Despite the current challenges, Health Catalyst is optimistic about its long-term prospects, particularly as it continues to innovate and expand its service offerings in the healthcare analytics market.